02-Nov-2026 19:02:12

CORRECTION; VALIANT LABORATORIES Q2 FY27 ; NET PROFIT UP 107% AT ₹0.43 CR (YOY), DOWN 98% (QOQ)

REVENUE UP 153% AT ₹117 CR (YOY), UP 1% (QOQ) EBITDA UP 6477% AT ₹5 CR (YOY), DOWN 82% (QOQ) MARGINS AT 4.4% VS 0.2% (YOY), 25.4% (QOQ)

Valiant Laboratories Limited